legochem biosicences inc
AstraZeneca, LegoChem Biosciences To Co-Develop Novel Antibiotics
AstraZeneca has licensed an antibiotic drug candidate from South Korea’s LegoChem Biosciences to treat drug-resistant bacterial infections.
AstraZeneca has licensed an antibiotic drug candidate from South Korea’s LegoChem Biosciences to treat drug-resistant bacterial infections.
